Abstract
Oligomer Aβ is the term utilized for multimeric but non-fibrillar forms of amyloid β-protein (Aβ). The most prominent property of oligomer Aβ is considered to be its solubility and structure. Here, we examined the histochemical localization of oligomer Aβ in AD brains. At present, little information is available on the structure and function of cerebral oligomer Aβ. We therefore studied the molecular localization of oligomer Aβ using a newly generated polyclonal mouse antisera against a variant Aβ with a deletion mutation of the 22nd glutamate that we found recently in a patient with familial Alzheimers disease. Intracellular as well as extracellular oligomer Aβ are herein discussed to define their structure and pathological roles in disease.
Keywords: Alzheimer disease, amyloid, Aβ, oligomer, synapse, recessive hereditary
Current Alzheimer Research
Title: Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form
Volume: 6 Issue: 2
Author(s): Kazuhiro Ito, Ken-Ichi Ishibashi, Takami Tomiyama, Tomohiro Umeda, Kei-Ichi Yamamoto, Erika Kitajima, Toshiki Idomoto, Toshie Nagatomo and Hiroshi Mori
Affiliation:
Keywords: Alzheimer disease, amyloid, Aβ, oligomer, synapse, recessive hereditary
Abstract: Oligomer Aβ is the term utilized for multimeric but non-fibrillar forms of amyloid β-protein (Aβ). The most prominent property of oligomer Aβ is considered to be its solubility and structure. Here, we examined the histochemical localization of oligomer Aβ in AD brains. At present, little information is available on the structure and function of cerebral oligomer Aβ. We therefore studied the molecular localization of oligomer Aβ using a newly generated polyclonal mouse antisera against a variant Aβ with a deletion mutation of the 22nd glutamate that we found recently in a patient with familial Alzheimers disease. Intracellular as well as extracellular oligomer Aβ are herein discussed to define their structure and pathological roles in disease.
Export Options
About this article
Cite this article as:
Ito Kazuhiro, Ishibashi Ken-Ichi, Tomiyama Takami, Umeda Tomohiro, Yamamoto Kei-Ichi, Kitajima Erika, Idomoto Toshiki, Nagatomo Toshie and Mori Hiroshi, Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form, Current Alzheimer Research 2009; 6 (2) . https://dx.doi.org/10.2174/156720509787602889
DOI https://dx.doi.org/10.2174/156720509787602889 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Comparative Neurophysiologic Study of Pain in Patients with Parkinson's Disease and Patients with Persistent Pain After Spinal Surgery
Neuroscience and Biomedical Engineering (Discontinued) Psychotropic Medications and the Treatment of Human Prion Diseases
CNS & Neurological Disorders - Drug Targets Posttranslational Modifications of Tau - Role in Human Tauopathies and Modeling in Transgenic Animals
Current Drug Targets Albumin Infusion Therapy in Stroke, Sepsis and the Critically Ill
Current Nutrition & Food Science Redox-Driven Events in the Human Immunodeficiency Virus Type 1 (HIV-1) Infection and their Clinical Implications
Current HIV Research The Interrelationship Between Disease and Ageing and the Implications for Longevity
Current Aging Science Metal-Score as a Potential Non-Invasive Diagnostic Test for Alzheimer’s Disease
Current Alzheimer Research The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Clinical Proteomics in Application to Predictive Diagnostics and Personalized Treatment of Diabetic Patients
Current Proteomics Reactive Oxygen Species and Antioxidants in the Pathophysiology of Cardiovascular Disease: Does the Actual Knowledge Justify a Clinical Approach?
Current Vascular Pharmacology Psychopathological Behaviour and Cognition in Morbid Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Imaging of Sigma1 Receptors in the Human Brain Using PET and [11C]SA4503
Central Nervous System Agents in Medicinal Chemistry Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective
CNS & Neurological Disorders - Drug Targets Phosphodiesterase Inhibitors for Cognitive Enhancement
Current Pharmaceutical Design The Effects of Lipid-Regulating Therapy on Haemostatic Parameters
Current Pharmaceutical Design Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases
CNS & Neurological Disorders - Drug Targets Separation and Purification of Small Peptides from Fermented Sesame Meal and Their Antioxidant Activities
Protein & Peptide Letters Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit
Current Neurovascular Research Neurocognition in the Psychosis Risk Syndrome: A Quantitative and Qualitative Review
Current Pharmaceutical Design The Effect of Psychological Stress and Social Isolation on Neuroimmunoendocrine Communication
Current Pharmaceutical Design